- Nachrichtendetail
-
05.03.2024 15:02:08 - dpa-AFX: *NEKTAR INITIATES PHASE 2B STUDY OF REZPEGALDESLEUKIN IN SEVERE ALOPECIA AREATA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
NEKTAR THERAPEUTICS | 165417 | Frankfurt | 1,521 | 24.05.24 08:03:09 | -0,069 | -4,34% | 0,000 | 0,000 | 1,521 | 1,521 |
